JLJing Liu

Jing Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jing Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Role of the miR-340-5p/IRF1/USP18 Axis in Neuroinflammation Associated with Epilepsy

    by Jing Liu, Yiting Wang, Bibi Yazgulyyeva, Dandan Sheng, Xinru Li, Luo Zhou, Bo Xiao, Weiping Liu

    Epilepsy is a prevalent neurological disorder, in which maladaptive neuroinflammation critically contributes to epileptogenesis. In this study, we identified a previously unrecognized signaling axis that regulates inflammatory responses and inflammatory cell death in experimental epilepsy. Integrated bioinformatic analyses of the GSE73878 and GSE18740 datasets, together with transcription factor and microRNA prediction databases, highlighted USP18 and its upstream regulators as key candidates. Functional and mechanistic validations were performed using lipopolysaccharide-stimulated BV2 microglia and pentylenetetrazole-induced mouse seizure models. Seizure severity and epileptic phenotypes were confirmed using the Racine scale assessments and EEG recordings. USP18 was markedly upregulated under epileptic conditions accompanied by increased pro-inflammatory cytokine release, apoptosis, and pyroptosis. Silencing USP18 attenuated neuroinflammation and reduced seizure severity. Mechanistically, interferon regulatory factor 1 (IRF1) was identified as a direct transcriptional activator of USP18, whereas miR-340-5p suppressed USP18 expression by targeting IRF1, thereby mitigating inflammatory signaling and neuronal injury. Collectively, these findings reveal a novel regulatory pathway linking microRNA-mediated control, interferon-responsive transcription, and inflammatory effector mechanisms in epilepsy, and suggest that targeting the miR-340-5p/IRF1/USP18 axis may represent a promising disease-modifying therapeutic strategy.

  • Exploratory Analysis of Autophagy-related Genes and Immune Infiltration in Human Hippocampal Tissue of Temporal Lobe Epilepsy

    by Jing Liu, Yiting Wang, Dandan Sheng, Xinru Li, Bibi Yazgulyyeva, Bo Xiao, Weiping Liu

    Epilepsy results from an imbalance between excitation and inhibition of neurons, with 30–40% of cases being temporal lobe epilepsy (TLE). This study aimed to prioritize autophagy-related genes and explore their potential links to immune features in human hippocampal tissue of TLE. Two hippocampal transcriptomic datasets (GSE202101 and GSE11882) were analyzed to identify autophagy-related differentially expressed genes (ARDEGs). Functional enrichment, regulatory network, and immune cell infiltration analyses were performed. LASSO regression and consensus clustering were applied. Exploratory assessment of the candidate gene signature was conducted in an independent dataset (GSE256068). Immunohistochemistry (IHC) on clinical specimens assessed protein expression of candidate signature genes. An eight‑gene candidate signature was derived, and subsequent PPI network analysis revealed LARP1, EIF4G1, and TSC2 as hub genes among them. Exploratory assessment in an independent dataset partially replicated the expression patterns of PYCARD, EIF4G1, and TSC2, whereas LARP1 showed an opposite expression trend; overall model performance remained modest. Increased activated mast cells were observed in TLE samples, while higher levels of plasma cells, CD8⁺ T cells, and regulatory T cells were observed in controls. Two exploratory clusters with distinct immune correlation patterns were identified. IHC showed upregulation of ABL1, TSC2, and SPP1 protein levels in TLE tissue. This study prioritizes a set of autophagy-related candidate genes in human hippocampal tissue and provides an exploratory framework linking them to local immune features in TLE. Further validation in larger independent cohorts is warranted before any clinical interpretation.